---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-037426"
form_type: "8-K"
ticker: "AGL"
cik: "0001831097"
company_name: "agilon health, inc."
filed_at: "2025-08-04T23:59:59+00:00"
generated_at: "2026-05-17T21:34:20.220314+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# CEO Sell resigns; agilon posts $104M Q2 net loss, suspends 2025 guidance

## Summary
- Steven Sell resigned as CEO/President and Board director effective July 29; Board reduced to seven directors.
- Executive Chairman Ron Williams appointed; Office of the Chairman formed to oversee interim operations.
- Q2 total revenue $1.39B (-6% YoY); net loss $104M vs $31M loss in Q2 2024.
- Medical margin negative $53M vs positive $106M; adjusted EBITDA loss $83M vs $3M loss.
- Full-year 2025 guidance suspended due to leadership change and market headwinds.

## SEC filing metadata
- accession: 0001628280-25-037426
- form_type: 8-K
- ticker: AGL
- cik: 0001831097
- company_name: agilon health, inc.
- filed_at: 2025-08-04T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 5.02, 5.03, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1831097/000162828025037426/0001628280-25-037426-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1831097/000162828025037426/agl-20250729.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-037426
- JSON: https://secwatch.observer/filing/0001628280-25-037426.json
- Plain text: https://secwatch.observer/filing/0001628280-25-037426.txt

## Key facts
- Governance Changes
  agilon health, inc.: Amended and restated the bylaws to adopt amendments relating to officer positions and technical updates reflecting Delaware law changes (effective 2025-07-29).
  - Change: bylaw amendment
  - Effective: 2025-07-29
  source text: On July 29, 2025, the Board amended and restated the by-laws of the Company (as amended, the “Amended and Restated By-laws”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1831097/000162828025037426/0001628280-25-037426-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.